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Introduction
Calcium oscillations triggered by fertilization stimulate the
release of the oocyte from metaphase II (M II) meiotic arrest
(Nuccitelli, 1991). Calcium induces inactivation of cytostatic
factor (CSF), thereby enabling inactivation of the M-phase
promoting factor (MPF) (Lorca et al., 1993). The molecular
mechanism of CSF activity is not well characterized; however,
we know that at least the c-mos/…/mitogen-activated protein
(MAP) kinase extracellular signal-regulated kinase 2
(ERK2)/p90rsk pathway is involved (Sagata et al., 1989;
Haccard et al., 1993; Gross et al., 1999) (reviewed by Masui,
2000). MPF is a complex of p34cdc2 protein kinase and cyclin
B (Labbé et al., 1989) (reviewed by Dorée and Hunt, 2002).
Inactivation of both CSF and MPF is necessary for the
successful transition to the first embryonic interphase and the
beginning of the developmental programme.
Early development preceding the midblastula transition in
Xenopus laevis depends entirely on the maternal information
stocked in mRNA and proteins accumulated during oogenesis.
Gene expression during early development (as well as during
oocyte maturation) depends largely on post-transcriptional
modification of maternal mRNAs (reviewed by Richter, 1999).
Polyadenylation and deadenylation of mRNA synthesized
before oocyte maturation are the most important mechanisms
involved in this process (Osborne and Richter, 1997). Different
classes of maternal mRNA were described in Xenopus oocytes
and embryos with respect to their pattern of polyadenylation/
deadenylation. The Eg family of mRNA containing Eg1/cdk2
(cyclin-dependent kinase 2), Eg2/Aurora A (kinase), Eg5
(kinesin-like protein) and c-mos are polyadenylated during
oocyte maturation due to the presence of a cytoplasmic
polyadenylation element (CPE) in the 3 ¢ -untranslated region
(3¢ -UTR) (Paris and Richter, 1990; McGrew and Richter, 1990)
and deadenylated following fertilization due to the presence of
an embryo deadenylation element (EDEN) also in the 3 ¢ -UTR
(Paillard et al., 1998). Most EDEN-containing mRNAs known
to date are involved in cell cycle regulation during early
development. For example, c-mos must be degraded and its
synthesis/accumulation downregulated to enable the exit from
M II-arrest after fertilization, as c-mos is a key component of
the CSF activity. Ectopic expression of c-mos following
fertilization induces cell cycle alterations and eventually cell
cycle arrest (Sagata et al., 1989; Murakami and Van de Woude,
1998; Murakami et al., 1999). Deadenylation of c-mos mRNA
(Paillard et al., 1998) after c-mos degradation (Lorca et al.,
1993) could play an important role in the elimination of c-mos
gene products during early development of Xenopus laevis
(Ueno and Sagata, 2002).
The EDEN-dependent deadenylation of maternal mRNA
depends on the presence of a trans-factor, EDEN binding
protein (EDEN-BP) (Paillard et al., 1998). EDEN-BP is a
homologue of human Nab50, or CUG-BP protein (Timchenko
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Deadenylation is an intimate part of the post-
transcriptional regulation of maternal mRNAs in embryos.
EDEN-BP is so far the only known member of a complex
regulating the deadenylation of maternal mRNA in
Xenopus laevis embryos in a manner that is dependent
on the 3¢ -untranslated region called EDEN (embryo
deadenylation element). In this report, we show that
calcium activation of cell-free extracts triggers EDEN
binding protein (EDEN-BP) dephosphorylation and
concomitant deadenylation of a chimeric RNA bearing
Aurora A/Eg2 EDEN sequence. Deadenylation of mRNA
deprived of EDEN sequence (default deadenylation) does
not change with egg activation. Kinase and phosphatase
inhibitors downregulate EDEN-dependent deadenylation
but they do not substantially influence default
deadenylation. Using indestructible D 90 cyclin B to revert
interphase extracts to the M-phase, we show that
modulation of EDEN-dependent deadenylation is
independent of M-phase promoting factor (MPF) activity.
These results suggest that the increase in EDEN-dependent
deadenylation following egg activation is achieved, at least
partially, via dephosphorylation and/or phosphorylation
of regulatory proteins, including EDEN-BP
dephosphorylation. This regulation proceeds in a manner
independent from MPF inactivation.
Key words: Aurora A, Eg2, EDEN-BP, Protein phosphorylation,
MPF, RNA deadenylation
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et al., 1996). This protein was shown to be involved in
maturation of mRNA in human somatic cells (Philips et al.,
1998). It is a phosphoprotein with a high potential to
be hyper- or hypophosphorylated. Phosphorylation and
dephosphorylation of CUG-BP was thought to be one of the
key mechanisms involved in regulation of the localization
(nuclear versus cytoplasmic) and activity of this protein in
mRNA maturation (Roberts et al., 1997).
Because EDEN-dependent deadenylation is active in early
Xenopus embryos, whereas the quantities of EDEN-BP protein
are similar before and after fertilization (Paillard et al., 1998),
we investigated whether post-translational modifications, like
phosphorylation or dephosphorylation, regulate this sequence-
specific deadenylation activity. In this paper we show that
EDEN-dependent deadenylation is sensitive to kinase and
phosphatase inhibitors. EDEN-BP is phosphorylated during
oocyte maturation and dephosphorylated following egg
activation. Dephosphorylation of EDEN-BP is calcium
dependent and correlates with the increase in the activity of
EDEN-dependent deadenylation. It suggests that these post-
translational modifications could regulate the efficiency of
EDEN-dependent deadenylation. MPF reactivation following
egg extract activation does not influence EDEN-dependent
deadenylation, suggesting that the regulation does not depend
directly on MPF activity. These results link calcium signals and
the cell cycle regulatory machinery to the deadenylation of
certain maternal mRNAs at the very beginning of the
embryonic development.
Materials and Methods
Oocytes and extracts
Oocytes were collected as described by Blot et al. (Blot et al., 2002).
The stage VI oocytes were then incubated overnight in Merriam buffer
(Merriam, 1971) [NaCl 88 mM, Ca(NO3)2 0.33 mM, KCl 1 mM,
CaCl2 0.41 mM, MgSO4 0.82 mM and HEPES 10 mM, pH 7.5].
Maturation was induced by addition of progesterone to 1 m M final
concentration in the buffer. Oocytes were collected at different times,
frozen in liquid nitrogen and kept at –70°C. 
Unfertilized eggs were dejellied with 2% L-cysteine pH 8.2 in XB
buffer (Murray, 1991) (KCl 100 mM, MgCl2 2 mM, HEPES 10 mM
pH 7.65, sucrose 50 mM) and washed in XB. Some of the eggs were
collected and the others were activated using 0.5 m g/ml calcium
ionophore A23187 for 2 minutes and then extensively washed in XB.
Eggs collected at different times after activation were frozen in liquid
nitrogen and kept at –70°C.
Extracts were prepared by the addition of homogenization buffer
(b -glycerophosphate 60 mM, p-nitrophenyl phosphate 15 mM, MOPS
25 mM pH 7.2, EGTA 15 mM, MgCl2 15 mM, dithiothreitol 2 mM,
Na-orthovanadate 1 mM, NaF 1 mM, di-Na-phenylphosphate 1 mM,
leupeptin 10 m g/ml, aprotinin 10 m g/ml, chymostatin 10 m g/ml and
pepstatin 10 m g/ml; 200 m l for 40 oocytes) to the thawing oocytes and
pipetting. After centrifugation at 12,000 g at 4°C the supernatant was
used for the experiment.
CSF extracts were prepared using joint protocols previously
described (Lohka and Masui, 1984) and Blow (Blow, 1993) with few
modifications: additional EGTA up to 7 mM final concentration and
sucrose 50 mM in the CSF extraction buffer (Blow et al., 1993) (KCl
50 mM, HEPES 50 mM pH 7.6, MgCl2 5 mM, EGTA 5 mM and DTT
2 mM) and two centrifugations at 15,000 g. Calcium-activated
extracts were prepared from CSF extracts supplemented with CaCl2
(0.8 mM final concentration). To check the integrity of our extracts,
10-20 m l of extract were incubated at 21°C for 1 to 1.5 hours with
sperm nuclei. The chromatin condensation (CSF extract) and
chromatin decondensation (activated extract) was visualized by
fluorescence and phase contrast microscopy using Hoechst dye in
fixing media. In some cases we also measured histone H1 kinase
activity or determined the state of phosphorylation of Cdc25
phosphatase by western blotting.
Calcium ionophore-activated embryo extract was prepared as
described by Legagneux et al. (Legagneux et al., 1995).
Drugs and recombinant proteins
Extracts were supplemented with recombinant bacterial D 90 sea
urchin cyclin B to 0.2 ng/ m l (Murray and Kirschner, 1989). Okadaic
acid (OA) (Goris et al., 1989) was used at a concentration of 1 m M,
and roscovitine (Meijer et al., 1997) at 100 m M. 
Transcripts
Two plasmid constructs pEg2-410 (Legagneux et al., 1992) and pEg2-
410a (Bouvet et al., 1994) were used. Both were derived from the 3 ¢ -
UTR of Eg2/Aurora A mRNA. Eg-410 is a substrate for EDEN-
dependent deadenylation. Eg2-410a RNA is a substrate for default
deadenylation as it contains neither a CPE nor an EDEN. These
plasmids were used to produce capped radiolabelled transcripts as
previously described (Legagneux et al., 1992). The radiolabelled
transcripts were purified by electrophoresis on a 4% polyacrylamide-
urea gel.
In vitro deadenylation and RNA analysis
The deadenylation experiments were realized in vitro as previously
described (Legagneux et al., 1995). In brief, 6 m l extracts were
incubated with 1 m l capped radiolabelled transcripts Eg2-410 and
Eg2-410a at 21°C for 1 to 3 hours. The transcripts were extracted as
described by Harland and Misher (Harland and Misher, 1988), then
precipitated and analysed by electrophoresis on 4% polyacrylamide-
urea gel and phosphorimaging. 0.5 m l of radiolabelled transcripts were
loaded directly on the gel without precipitation (lanes T) as a size
marker for the input RNA, the starting point of deadenylation.
Immunoprecipitation 
Anti-EDEN-BP sepharose beads were prepared with anti-EDEN-BP
rabbit serum (Paillard et al., 1998) loaded on protein A-sepharose
beads. The IgG were then covalently coupled to the beads using
dimethyl pimelimidate coupling agent according to standard
procedure.
Oocyte or unfertilized egg extracts were added to anti-EDEN-BP
sepharose beads (200 m l of extract for 20 m l of beads) and incubated
at 4°C for 40 minutes followed by extensive washing in bead buffer
(Tris 50 mM pH 7.4, NaF 5 mM, NaCl 250 mM, EDTA 5 mM, EGTA
5 mM, Nonidet P-40 0.1%, leupeptin 10 m g/ml, aprotinin 10 m g/ml,
chymostatin 10 m g/ml and pepstatin 10 m g/ml). The bound material
was either used for further experiment or eluted at 90°C in elution
buffer (Tris 62.5 mM pH 6.8, 2% sodium dodecyl sulfate) and
collected after centrifugation. Concentrated Laemmli denaturating
buffer was added to the eluted material. Samples were boiled before
analysis. 
Phosphatase assays 
For these experiments the extracts were made in homogenization
buffer without di-Na phenyl phosphate and p-nitrophenyl phosphate.
The phosphatase l (Lambda Protein phosphatase P0753S Biolabs)
was incubated according to the manufacturer’s instructions with either
nonactivated egg extract or ionophore-activated egg extract (40
units/m l of extract) or with EDEN-BP immunoprecipitated from
unfertilized egg extract on sepharose beads (160 Unit/ m l of beads).
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The incubation was realized at 30°C for 30 minutes to 2 hours. The
reaction was stopped by addition of Laemmli denaturating buffer. The
samples were boiled before analysis.
Electrophoresis and western blotting
Protein was analysed on a sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS/PAGE) gel (Laemmli, 1970); when required the
separating gel consisted of 15% acrylamide and 0.13% bisacrylamide
(ratio 29.8:0.2) to allow better separation of different forms of EDEN-
BP (Anderson et al., 1973). Otherwise, 10% SDS/PAGE gels were
used (Laemmli, 1970). Separated proteins were transferred to
nitrocellulose membranes (Hybond C; Amersham) according to
standard procedures and probed with either purified rabbit polyclonal
anti-EDEN-BP antibodies 1/1000 (nonimmunoprecipitated extracts),
polyclonal anti-EDEN-BP guinea pig serum 1/3000
(immunoprecipitation experiments) or anti-Cdc25 (gift from Marcel
Dorée, CRBM, Montpellier, France) and followed by alkaline
phosphatase-coupled secondary antibody (Sigma) 1/30000.
Results
EDEN-dependent deadenylation is accelerated on
calcium addition to the CSF extract 
The influence of calcium on EDEN-dependant deadenylation
was evaluated using CSF extracts prepared as described in
Materials and Methods. The extracts were supplemented with
CaCl2 to a final concentration of 0.8 mM, as well as with
radiolabelled chimeric mRNAs: Eg2-410 that contains the
EDEN sequence and Eg2-410a that does not contain the EDEN
sequence. These RNAs are derived from the 3 ¢ -UTR of Eg2
mRNA (Bouvet et al., 1994). The functional activity of these
extracts was verified by measuring the accumulation of the
poly(A)– form of the chimeric RNAs. Samples were collected
at 1, 2 and 3 hours after adding the radiolabelled transcripts.
Deadenylation of EDEN-containing RNA is processive
(Legagneux et al., 1995), which is shown by the accumulation
of the deadenylated form, whereas the initial adenylated
form persists (see A– of Eg2-410 in Fig. 1A); default
dedeadenylation is distributive (Legagneux et al., 1995), which
is visible as a smear in the gel (see A– of Eg2-410a in Fig. 1A).
The analysis of the transcripts shows a weak EDEN-dependent
deadenylation (Eg2-410 RNA) in CSF extract (Fig. 1A, left
panel) that is substantially increased in extracts activated with
0.8 mM calcium (Fig. 1A, right panel). Only a slight change
in the pattern of accumulation of deadenylated forms of Eg2-
410a chimeric RNA was detected on calcium-induced
activation of the extracts (Fig. 1A, compare Eg2-410a in left
and right panels). Interphase versus M-phase state of extracts
was checked by observing the chromatin condensing or
decondensing activity; demembranated sperm nuclei were
added followed by Hoechst staining and phase contrast
observation (Fig. 1B). In CSF extracts we found condensed
chromosomes forming metaphase plates (Fig. 1B, left),
whereas interphase nuclei were formed in activated extracts
(Fig. 1B, right). Therefore, the increase in calcium ion
concentrations that induced activation of CSF extracts
triggered a substantial acceleration of the EDEN-dependent
deadenylation, whereas only a slight modification in the
dynamics of default deadenylation was observed.
Calcium triggers changes in the electrophoretic mobility
of EDEN-BP in CSF extract and M II oocytes
EDEN-BP migrates as a doublet of 55/53 kDa in SDS/PAGE
gels (Legagneux et al., 1992). Therefore, we evaluated the
effect of increasing the concentration of calcium ions in the
CSF extracts on the electrophoretic mobility of EDEN-BP.
Using Anderson’s modified SDS/PAGE gels (Anderson et al.,
1973), we detected a more complex pattern of EDEN-BP
electrophoretic mobility. Three bands (Fig. 2A,B; named a, b,
c) were observed. The uppermost weak band (a) is only visible
in CSF extracts collected before calcium addition. The second
band (b) corresponds to the major band in the CSF extracts and
its intensity decreases after calcium activation. This decrease
appears sensitive to the amount of calcium added (compare
extracts 3 hours after activation with 0.4, 0.8 and 1.6 mM
CaCl2, Fig. 2A). The lower major band (c) is clearly observed
in the activated extracts; however, it is also present as a minor
band in CSF extracts. The intensity of this band increases in
parallel with the increase in calcium concentration (compare
extracts 3 hours after activation with 0.4, 0.8 and 1.6 mM
CaCl2, Fig. 2A). 
To determine whether the calcium-induced changes in the
electrophoretic mobility of EDEN-BP occur in vivo, we
studied the protein in parthenogenetically activated M II
oocytes. The protein was detected by western blotting either
directly (data not shown) or after immunoprecipitation (Fig.
2B). In nonactivated eggs (arrested in M II of meiosis),
similarly to CSF extracts, three EDEN-BP bands (a, b, c) with
a strong upper major band (b) and a very weak lower band (c),
were detected (Fig. 2B, NA; compare with untreated CSF
extracts, time 0, in Fig. 2A). In activated eggs the uppermost
band (a) was absent, the intensity of major band (b)
Fig. 1. Acceleration of EDEN-dependent
deadenylation in calcium-activated CSF extract.
(A) Capped, radiolabelled transcript Eg2-410 and
Eg2-410a were incubated in CSF- or calcium (0.8
mM)-activated extracts for 1, 2 or 3 hours. After
extraction and precipitation RNAs were analysed on
urea/acrylamide 4% gels. The positions of the
different forms of the transcripts are indicated:
(A+), fully adenylated (A65) form, and (A–), fully
deadenylated form. The lane (T) corresponds to the fully adenylated radiolabelled
transcripts without previous incubation with extract and precipitation. (B) Sperm
nuclei chromatin was stained with Hoechst dye and observed in fluorescence and
phase contrast. Condensed sperm chromosomes in the CSF extract (left) and
decondensed nuclei in calcium activated extract (right).
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significantly diminished and the lower major band (c)
dramatically increased (Fig. 2B, A). Immunoprecipitation of
EDEN-BP enabled us to more clearly visualize the
intermediate bands (b¢ ), sometimes visible as a doublet in
between the major bands (b) and (c) (Fig. 2B, A). Therefore,
on egg activation the electrophoretic mobility of EDEN-BP
increases as observed in the calcium-treated CSF extracts. 
The electrophoretic mobility changes in EDEN-BP occur
during oocyte maturation and following egg activation
To characterize the dynamics of the changes in the
electrophoretic mobility of EDEN-BP, we studied the protein
in detail during oocyte maturation and following egg
activation. Samples of maturing oocytes were collected every
hour following progesterone addition (Fig. 3A) and at short
intervals following parthogenetic activation of M II oocytes
with calcium ionophore (Fig. 3B), and analysed as above.
Stage VI prophase I-arrested oocytes contain two forms of
EDEN-BP: the major lower band (c) and a smear of minor ones
corresponding to the bands (b ¢ ). Four hours after the addition
of progesterone, when 50% of oocytes had undergone germinal
vesicle breakdown (GVBD), as judged by the appearance of
the maturation spot, the mobility of EDEN-BP changed and
the upper band (b) appeared. The uppermost band (a) was
detected after 6 hours of progesterone
treatment. After 7 hours (100% GVBD), the
intensity of the upper bands (a) and (b) clearly
increased, whereas the intensity of the lower
(c) band decreased (Fig. 3A). 
Following activation of M II oocytes we
observed a rapid decrease in the intensity of
the upper bands (a) and (b) (Fig. 3B). The
uppermost band (a) disappeared within 15
minutes, whereas the band (b) persisted until
2 hours postactivation. The intensity of lower
bands (b ¢ ) and (c) increased concomitantly.
Thus, EDEN-BP undergoes rapid post-
translational modifications at the time of
the GVBD during oocyte maturation and
following egg activation. The dynamics of
these changes in EDEN-BP electrophoretic
mobility resemble those observed for other
proteins that undergo cell-cycle-dependent
phosphorylation during GVBD and dephosphorylation
following entry into development (e.g. ERK2 MAP kinase)
(Ferrell et al., 1991).
EDEN-BP is post-translationally modified by
phosphorylation/dephosphorylation
To verify whether the electrophoretic changes of EDEN-BP
were due to changes in the phosphorylation of the protein,
extracts were treated with the phage l phosphatase at 30°C for
0, 0.5 or 1 hour. The samples were then analysed by
SDS/PAGE and anti-EDEN-BP western blotting. The phage l
phosphatase treatment caused an increase in the electrophoretic
mobility of EDEN-BP, whereas without phage l phosphatase
treatment, the major upper band (b) of EDEN-BP was still
detectable after 1 hour of incubation at 30°C (Fig. 4A). To
show the direct effect of the phage l phosphatase on EDEN-
BP, we immunoprecipitated EDEN-BP followed by l
phosphatase treatment. In these conditions a similar
modification of EDEN-BP was observed (Fig. 4B). However,
the conversion of the immunoprecipitated protein appeared to
be less complete and residual amounts of bands (a) and (b)
were sometimes observed. This reduced conversion to the
dephosphorylated form could be due to a masking effect
because EDEN-BP is complexed with the antibodies during the
phosphatase treatment. The data presented show that the phage
l phosphatase treatment mimics to a large part the down shift
Journal of Cell Science 116 (13)
Fig. 2. Changes in the electrophoretic mobility of EDEN-BP is triggered by calcium.
(A) Increasing amounts of CaCl2 were added to activate CSF extract. The extracts were
incubated for 3 hours, analysed on 15% Anderson SDS/PAGE gels, blotted and reacted
with anti-EDEN-BP antibody. (B) Proteins extracted from nonactivated eggs (NA) and
calcium ionophore-activated eggs (A) were immunoprecipitated on proteinA-sepharose
beads covalently coupled with anti-EDEN-BP antibodies. Extracts from nonactivated
eggs were also loaded on control proteinA-sepharose beads that were not in contact with
the antibody (C). The bound material was analysed by electrophoresis and
immunoblotted with anti EDEN-BP antibodies. a, b, b ¢ and c indicate the different
electrophoretic forms of EDEN-BP.
Fig. 3. Electrophoretic mobility of EDEN-BP changes during oocyte
maturation and activation. (A) Stage VI oocytes were incubated in
Merriam buffer and maturated in vitro by addition of 1 m M
progesterone. Samples of 20 oocytes were collected at 0, 1, 2, 4 and
5-9 hours after progesterone addition. The GVBD status was
estimated as the percentage of oocytes showing the maturation spot
(% GVBD). The samples were extracted, analysed by electrophoresis
and immunoblotted with anti EDEN-BP antibody. (B) Unfertilized
eggs were treated (+) or not (–) with calcium ionophore. Samples of
ten parthenogenetic embryos were collected every 15 minutes during
the first hour postactivation, and then every 30 minutes. Extracts
were analysed as described above. The positions of different
electrophoretic forms of EDEN-BP are indicated on the right of the
blot.
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of EDEN-BP observed after calcium addition to CSF extract
or calcium ionophore treatment of M II oocytes. These
experiments show that the post-translational modifications
of EDEN-BP are, at least in part, due to phosphorylation
and dephosphorylation. EDEN-BP is phosphorylated during
maturation and dephosphorylated following egg activation.
Kinase and phosphatase inhibitors downregulate EDEN-
dependent deadenylation
A large number of kinases are inactivated on egg activation
(Karsenti et al., 1987). The temporal correlation between
the beginning of EDEN-BP dephosphorylation and the
acceleration of EDEN-dependent deadenylation following egg
activation suggests that the two processes, which are triggered
by free calcium increase, could be due to a change in the
equilibrium between kinases and phosphatases activities.
Therefore, we determined whether kinase and phosphatase
inhibitors could influence the process of EDEN-dependent
mRNA deadenylation.
To inhibit a broad range of serine/threonine kinases we used
roscovitine at high concentration (100 m M) added to CSF
extract activated by the addition of CaCl2 (Fig. 5). At this
concentration roscovitine inhibits a large spectrum of kinases
(Meijer et al., 1997). We observed a complete inhibition of the
EDEN-dependent deadenylation; no poly(A)– form of Eg2-410
chimeric RNA was detected even after 3 hours of incubation
(Fig. 5). Only slight changes (higher accumulation of
intermediate forms of Eg2-410a chimeric RNA) in the
dynamics of the default deadenylation were observed.
Similar experiments were performed by inhibiting a broad
range of phosphatases. A mixture of concentrated phosphatase
inhibitors was added to the CSF extract containing chimeric
RNAs before CaCl2 addition. EDEN-dependent deadenylation
was very efficiently arrested by these inhibitors both in CSF
and calcium-activated extracts (data not shown). 
Okadaic acid is a potent inhibitor of phosphatases 1 and 2A
(Goris et al., 1989). Therefore, using this drug enabled us to
identify the spectrum of phosphatases inhibiting EDEN-
dependent deadenylation. CSF extracts supplemented with OA
were incubated at 21°C for 15 minutes and then activated with
CaCl2, and radiolabelled transcripts were added. We observed
that OA inhibited the deadenylation process in calcium-
activated extracts (Fig. 6A). The inhibition of EDEN-
dependent deadenylation was correlated with the
inhibition of the dephosphorylation of EDEN-BP (Fig.
6B). The dynamics of default deadenylation was only
slightly modified by OA, although the accumulation of
several partially deadenylated products became visible.
From these experiments, we can conclude that
EDEN-dependent deadenylation is regulated by a
balance between phosphorylation and dephosphorylation
activities and that this process is sensitive to OA.
MPF pathway does not inhibit EDEN-dependent
deadenylation
MPF is finely regulated via phosphorylation/
dephosphorylation. Cdc25 phosphatase is a major
activator of MPF and this phosphatase is itself
activated by a series of phosphorylations on the entry
into the M-phase (Kumagai and Dunphy, 1991; Gautier et al.,
1991). MPF activity depends on the stability of cyclin B
(Murray and Kirschner, 1989; Murray et al., 1989).
Moreover, OA is known to indirectly activate MPF in
Xenopus oocytes and extracts (Goris et al., 1989; Rime et al.,
1990; Jessus et al., 1991; Lorca et al., 1991). Therefore, the
sensitivity of EDEN-dependent deadenylation to OA could be
due, in part, to activation of MPF. To determine whether this
activity interferes with the process of EDEN-dependent
deadenylation we specifically activated MPF via the addition
of indestructible D 90 cyclin B of sea urchin into CSF extracts
followed by calcium treatment (Fig. 7A). Addition of
exogenous D 90 cyclin B into CSF extract treated with Ca2+
maintained condensed chromosomes (Fig. 7A, lower panel,
compare left and middle images), indicating that the extract
remained in M-phase despite calcium addition, whereas
interphase nuclei were present in calcium-activated extract
(Fig. 7A, lower panel, right). However, the high MPF activity
in the extract had no effect on EDEN-dependent
deadenylation (Fig. 7A, upper panel).
Fig. 4. Changes in the electrophoretic mobility of EDEN-BP are due to its
phosphorylation and dephosphorylation. (A) Extracts from non-activated
eggs and calcium ionophore-activated eggs were incubated at 30°C with (+)
or without (–) phophatase l for the indicated times. The extracts were
analysed on 15% Anderson SDS/PAGE and immunoblotted with anti-EDEN-
BP antibodies. (B) EDEN-BP immunoprecipitated from unfertilized egg
extract was incubated with phospatase l and treated as above. The different
electrophoretic forms of EDEN-BP are indicated on the left.
Fig. 5. Roscovitine downregulates EDEN-dependent deadenylation.
Roscovitine was added (+) or not (–) to calcium-activated CSF
extract to a final concentration of 100 m M. Capped, radiolabelled
transcript Eg2-410 and Eg2-410a were incubated in the extract for 1,
2 or 3 hours at 21°C. After extraction and precipitation radiolabelled
RNAs were analysed on urea/acrylamide 4% gel. The lane (T)
corresponds to the fully adenylated radiolabelled transcripts without
previous incubation with extract and precipitation.
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To check whether MPF activity could affect the
deadenylation activity, which had already been accelerated on
egg activation, we added D 90 cyclin B to ionophore-activated
embryo extract and followed EDEN-dependent deadenylation
(Fig. 7B). In parallel, we checked the inhibitory effect of OA
in the same extract, as well as the combined effect of both D 90
cyclin B and OA (Fig. 7B). As expected, D 90 cyclin B restored
an M-phase state in the extract, which was confirmed in
western blot with anti-Cdc25; the disappearance of the fast
migrating (dephosphorylated) band is concomitant with the
appearance of a new, upshifted band (Fig. 7B, lane 2 in the
lower panel). The addition of D 90 cyclin B did not affect
EDEN-dependent deadenylation in this extract when compared
with the control, interphase extract (Fig. 7B, upper panel,
compare experiments 1 and 2). As already shown for the
calcium activated CSF extract, 1 m M OA slowed this process
and this reduced rate of deadenylation was not affected when
the OA treatment extract was supplemented with D 90 cyclin B
(Fig. 7B, compare experiments 3 and 4). As expected, the
combined effect of OA and D 90 cyclin B treatment induced a
more pronounced phosphorylation of Cdc25 (Fig. 7B, lower
panel, lane 4). Such a combined treatment seems to have a
synergistic effect on the M-phase state of the extract, but does
not influence significantly EDEN-dependent deadenylation
compared with the OA treatment alone (Fig. 7B, upper panel,
compare experiments 3 and 4). From these experiments we
conclude that EDEN-dependent deadenylation of RNA is not
affected by MPF activity.
Discussion
Calcium signalling upregulates EDEN-dependent
deadenylation on egg activation
Calcium plays a major role in egg activation on fertilization or
parthenogenetic activation (Stricker, 1999; Runft et al., 2002).
Transient rises in intracellular Ca2+ are of great importance for
numerous biochemical and cell biological processes necessary
for further development. Here, we showed that calcium-
mediated activation of CSF extracts greatly enhanced EDEN-
dependent deadenylation activity, as well as dephosphorylation
of EDEN-BP, the only protein known so far to be involved in
this process. Moreover, we showed that the same modifications
of EDEN-BP occurred when M II oocytes were
parthenogenetically activated via calcium ionophore treatment.
Because Xenopus laevis EDEN-containing maternal mRNAs
are deadenylated following fertilization (Paris et al., 1988;
Paris and Philippe, 1990), we believe that the same
calcium-dependent mechanism triggers EDEN-dependent
deadenylation of maternal mRNAs on fertilization.
Deadenylation of maternal mRNAs that contain EDEN-
sequence (Eg family and c-mos) (Bouvet et al., 1994; Paillard
et al., 1998) results in their translational arrest (Ezzeddine
et al., 2002; Ueno and Sagata, 2002). Therefore, our data
provide a link between calcium signalling and translational
repression of maternal genes during early development of
Xenopus laevis. We also observed that an increase in the
amount of calcium added to CSF extract, induced a more
pronounced dephosphorylation of EDEN-BP. Fertilization
generates transient intracellular calcium waves. Adding
supraphysiological amounts of calcium (1.6 mM) to CSF
extract may in one step induce rapid modifications of numerous
biochemical processes that in concert enhance EDEN-BP
dephosphorylation.
Phosphorylation and dephosphorylation modulate
EDEN-dependent deadenylation of mRNA
Calcium waves that occur after fertilization provoke a rapid
inactivation of CSF and MPF activity, resulting in metaphase
to anaphase transition followed by the first embryonic
interphase (Lorca et al., 1993) (reviewed by Maller, 1998).
Inactivation of MPF via cyclin B degradation (Murray
et al., 1989) triggers changes in the phosphorylation/
dephosphorylation equilibrium in favour of dephosphorylation
(Karsenti et al., 1987). Inactivation of multiple kinases
participates in this process and correlates with
dephosphorylation of EDEN-BP. Using nondegradable sea
urchin D 90 cyclin B, which enables the MPF kinase activity to
be artificially maintained in calcium-treated CSF extracts, or
to activate MPF in interphase extracts, we show that the
EDEN-dependent deadenylation is independent of MPF
activity. In contrast, OA reduces the activity of EDEN-
dependent deadenylation. OA is known to activate MPF
and ERK2 MAP kinase besides inactivating phosphatases PP1
and PP2 (Jessus et al., 1991). Whether the effect of OA on
EDEN-dependent deadenylation is via ERK2 activation or
phosphatase inactivation is not clear at present. However, in
preliminary experiments we observed that inactivation of
ERK2 by the addition of recombinant phosphatase CL 100
to OA-treated extract restored the EDEN-dependent
deadenylation activity (our unpublished results). In addition,
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Fig. 6. Okadaic acid downregulates EDEN-dependent deadenylation
and inhibits dephosphorylation of EDEN-BP. (A) Okadaic acid (OA)
at 1 m M final concentration was added (+) or not (–) to CSF extract
and incubated for 15 minutes at 21°C. Both extracts were then
supplemented with CaCl2 (to final concentration of 0.8 mM) and
incubated at 21°C for 1, 2 or 3 hours with radiolabelled transcripts
Eg2-410 and Eg2-410a. RNA were extracted, analysed on
urea/polyacrylamide 4% gel and autoradiography. The lane (T)
corresponds to the fully adenylated radiolabelled transcripts without
previous incubation with extract and precipitation. (B) Proteins were
resolved on 15% Anderson SDS/PAGE, transferred to membrane and
immunoblotted with anti-EDEN-BP antibody. The different
electrophoretic forms of EDEN-BP are indicated both on the left and
on the right.
2703EDEN-dependent deadenylation and phosphorylation
the timing of MAP kinase ERK2 activation and inactivation
during oocyte maturation and after fertilization correlates with
phosphorylation and dephosphorylation of EDEN-BP (Ferrell
et al., 1991; Abrieu et al., 1996; Chau and Shibuya, 1999). A
positive feedback between MPF and ERK2 activation in CSF
extracts through the phosphorylation of c-mos, an upstream
regulator of the ERK2, was reported recently by Castro et al.
(Castro et al., 2001). In some of our experiments in which D 90
cyclin B was added to CSF extracts followed by calcium
addition, we observed an intermediate rate of EDEN-
dependent deadenylation compared with CSF extracts and
calcium-activated extracts (data not shown). In these extracts
we detected the phosphorylated form of ERK2 MAP kinase.
This suggests that the feedback loop described by Castro et al.
(Castro et al., 2001) is provoking ERK2 MAP kinase activation
in these extracts, supposedly when c-mos was not totally
degraded. Further studies are necessary to examine the
potential role of ERK2 MAP kinase, and/or a combined role
of MPF and MAP kinase pathways, in the regulation of EDEN-
dependent deadenylation and, in particular, of EDEN-BP
phosphorylation.
The insensitivity of EDEN-dependent deadenylation to MPF
contrasts with the recent data by Groisman et al. (Groisman et
al., 2002) showing that cyclin B1 mRNA polyadenylation is
stimulated via MPF and that its deadenylation is induced by
MPF inactivation. There is no proof that cyclin B1 3 ¢ -UTR
contains an EDEN, suggesting that the deadenylation of this
mRNA is independent of EDEN-BP. Therefore, two groups of
maternal Xenopus mRNAs can be distinguished on the basis
of their behavior regarding deadenylation during early
Fig. 7. MPF activation through D 90 cyclin B addition to Ca2+, or ioniphore-activated extracts does not influence EDEN-dependent
deadenylation. A. Nondegradable sea urchin D 90 cyclin B was added (+) or not (–) to CSF extract at final concentration of 0.2 ng/m l and
incubated for 15 minutes at 21°C to allow its association with cdk1 and the formation of a pool of stable MPF. Both extracts were then
supplemented with CaCl2 (to final concentration 0.8 mM) and incubated at 21°C for 1, 2 or 3 hours with radiolabelled transcripts Eg2-410 and
Eg2-410a. RNA. Upper panel: autoradiography of the extracted RNAs separated on a urea/acrylamide 4% gel. The lane (T) corresponds to the
fully adenylated radiolabelled transcripts without previous incubation with extract and precipitation. The two extracts deadenylate chimeric
RNAs with similar dynamics independently from the presence or absence of D 90 cyclin B. Lower panel: sperm nuclei were incubated with
extracts and stained with Hoechst dye following observation in fluorescence and phase contrast. Condensed sperm chromosomes in the control
CSF extract (left) and in the calcium activated CSF extract with D 90 cyclin B (middle) were found at the end of the experiment, whereas
decondensed nuclei were present in calcium activated CSF extract (right). This confirms that D 90 cyclin B-supplemented extract was in M-
phase similarly to the control, untreated CSF extract. B. Nondegradable sea urchin D 90 cyclin B (final concentration 0.2 ng/ m l), OA (final
concentration 1 m M), or both, were added to ionophore-activated eggs extract prepared 45 minutes after egg activation. The extracts were
incubated for 15 minutes at 21°C to allow association of exogenous cyclin with cdk1 and formation of stable MPF or to inactivate protein
phosphatases in the case of OA. Then they were supplemented with radiolabelled Eg2-410 transcript and further incubated at 21°C for 3 hours.
RNA and proteins were analysed as indicated in Materials and Methods. Upper panel: autoradiography of the extracted RNAs separated on
urea/acrylamide 4% gel. The lane (T) corresponds to the fully adenylated radiolabelled transcripts without previous incubation with extract and
precipitation. Untreated, as well as D 90 cyclin B-supplemented extracts dedenylate Eg2-410 transcript rapidly (experiments 1 and 2), whereas
OA- and OA+ D 90 cyclin B-supplemented extracts deadenylate only slightly Eg2-410 transcript (experiments 3 and 4). Lower panel: western
blot with an anti-Cdc25 antibody. The fast migrating, lowest band represents dephosphorylated (inactive) form of Cdc25. The upshifted forms
of Cdc25 produced by different treatments represent phosphorylated (active) forms of the Cdc25 phosphatase. Untreated extract contains
inactive Cdc25 (lane 1), whereas D 90 cyclin B-supplemented extract contains activated form of the phosphatase (lane 2) indicating induction of
the M-phase. OA-treated and OA+D 90 cyclin B-treated extracts contain phosphorylated forms of Cdc25 (lanes 3 and 4, respectively). In
OA+ D 90 cyclin B containing extract (lane 4) Cdc25 is phosphoryletd to higher degree than in OA-treated extract (lane 3), indicating a
synergistic effect of D 90 cyclin B and OA on Cdc25 phosphorylation.
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development: namely, MPF- or cell-cycle-dependent
deadenylation, like cyclin B1 mRNA (Groisman et al., 2002),
and MPF-independent, but activation-dependent deadenylation,
like Eg2 (this paper). Because calcium is as an important
regulator of the cell cycle, we cannot exclude that mRNA
deadenylation is controlled by cytoplasmic calcium in both
cases.
EDEN-BP phosphorylation and dephosphorylation seems a
very complex process. We could distinguish four different
forms of this protein on western blots. The complex pattern
of EDEN-BP phosphorylation suggests that multiple
phosphorylation sites are modified during oocyte maturation
and following egg activation. The inhibitory effects of both
kinase and phosphatase inhibitors on EDEN-dependent
deadenylation supports the hypothesis of a network of kinases
and phosphatases controlling this process.
Could EDEN-BP phosphorylation regulate EDEN-
dependent deadenylation?
EDEN-BP is a good candidate for the regulatory molecule
involved in the modulation of EDEN-dependent
deadenylation on M II oocyte fertilization or activation. After
calcium ionophore-induced activation this protein undergoes
a series of dephosphorylations. The hyperphosphorylated
band (a) disappears rapidly, whereas the intensity of the
dephosphorylated band (c) increases to reach a maximum
2.5 to 3 hours after egg activation. The intensity of the
hyperphosphorylated band (b), which is the major band in
CSF extracts, decreases gradually and disappears 2 hours
after activation. This correlation suggests that
phosphorylation of EDEN-BP could be involved in the
inhibition of EDEN-dependent deadenylation. However,
EDEN-BP is part of a multimeric complex of high molecular
weight (Legagneux et al., 1995) that probably contains
several other factors required for deadenylation. Therefore,
at present we can not exclude that changes in the
phosphorylation of one or several of these factors are not
involved in the regulation of EDEN-dependent deadenylation.
Identification of the amino acids of EDEN-BP that are
phosphorylated on oocyte maturation and studies of mutant
proteins will permit us to evaluate the exact role of EDEN-
BP phosphorylation and dephosphorylation during oocyte
maturation and early embryonic development. 
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